Organon & Co Cash Flow-to-Debt Ratio
Organon & Co cash flow-to-debt ratio. Organon & Co (OGN) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2026, meaning its operating cash flow of $107.00 Million could theoretically repay 0% of its total liabilities ($12.17 Billion) in one year. Check how aggressively does Organon & Co reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Organon & Co (2018–2025)
Cash flow-to-debt ratio of Organon & Co from 2018 to 2025. Historical debt coverage capacity for Organon & Co across 8 annual periods. Check OGN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Organon & Co Cash Flow-to-Debt Ratio by Year (2018–2025)
Organon & Co cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Organon & Co. For the full cash flow conversion analysis, see OGN cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $700.00 Million | $12.12 Billion | ▼ -22.3% |
| 2024 | 0.07x | $939.00 Million | $12.63 Billion | ▲ +12.9% |
| 2023 | 0.07x | $799.00 Million | $12.13 Billion | ▼ -9.0% |
| 2022 | 0.07x | $858.00 Million | $11.85 Billion | ▼ -64.1% |
| 2021 | 0.20x | $2.46 Billion | $12.19 Billion | ▼ -57.4% |
| 2020 | 0.47x | $2.19 Billion | $4.62 Billion | ▼ -39.9% |
| 2019 | 0.79x | $2.77 Billion | $3.51 Billion | ▼ -11.4% |
| 2018 | 0.89x | $3.69 Billion | $4.15 Billion | — |